119 related articles for article (PubMed ID: 23089320)
21. Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells?
Sellheyer K; Nelson P; Krahl D
Br J Dermatol; 2009 Dec; 161(6):1317-22. PubMed ID: 19659472
[TBL] [Abstract][Full Text] [Related]
22. Dermatofibroma and dermatofibrosarcoma protuberans: a comparative ultrastructural study.
Dominguez-Malagon H; Valdez-Carrillo Mdel C; Cano-Valdez AM
Ultrastruct Pathol; 2006; 30(4):283-91. PubMed ID: 16971353
[TBL] [Abstract][Full Text] [Related]
23. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
Abenoza P; Lillemoe T
Am J Dermatopathol; 1993 Oct; 15(5):429-34. PubMed ID: 7694515
[TBL] [Abstract][Full Text] [Related]
24. Phosphohistone-H3 and Ki67: Useful Markers in Differentiating Dermatofibroma From Dermatofibrosarcoma Protuberans and Atypical Fibrohistiocytic Lesions.
Agarwal A; Gopinath A; Tetzlaff MT; Prieto VG
Am J Dermatopathol; 2017 Jul; 39(7):504-507. PubMed ID: 28609344
[TBL] [Abstract][Full Text] [Related]
25. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
Mentzel T; Schärer L; Kazakov DV; Michal M
Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
[TBL] [Abstract][Full Text] [Related]
26. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
Kovarik CL; Hsu MY; Cockerell CJ
J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
[TBL] [Abstract][Full Text] [Related]
27. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
29. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
[TBL] [Abstract][Full Text] [Related]
30. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?
Horenstein MG; Prieto VG; Nuckols JD; Burchette JL; Shea CR
Am J Surg Pathol; 2000 Jul; 24(7):996-1003. PubMed ID: 10895822
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical study of membrane type-matrix metalloproteinases (MT-MMPs) and matrix metalloproteinase-2 (MMP-2) in dermatofibroma and malignant fibrous histiocytoma.
Ohnishi Y; Ito Y; Tajima S; Ishibashi A; Arai K
J Dermatol Sci; 2002 Feb; 28(2):119-25. PubMed ID: 11858950
[TBL] [Abstract][Full Text] [Related]
32. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
[TBL] [Abstract][Full Text] [Related]
33. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue.
Kutzner H
J Am Acad Dermatol; 1993 Apr; 28(4):613-7. PubMed ID: 7681857
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors.
Taniuchi K; Yamada Y; Nonomura A; Takehara K
J Cutan Pathol; 1997 Aug; 24(7):393-7. PubMed ID: 9274955
[TBL] [Abstract][Full Text] [Related]
35. Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans.
Zelger BW; Ofner D; Zelger BG
Histopathology; 1995 Jun; 26(6):519-27. PubMed ID: 7545142
[TBL] [Abstract][Full Text] [Related]
36. Comparison of p53 expression in dermatofibrosarcoma protuberans and dermatofibroma: lack of correlation with proliferation rate.
Díaz-Cascajo C; Bastida-Iñarrea J; Borrego L; Carretero-Hernández G
J Cutan Pathol; 1995 Aug; 22(4):304-9. PubMed ID: 7499569
[TBL] [Abstract][Full Text] [Related]
37. Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans: a comparison with fibroblast and endothelial cells of the dermis.
Bonish BK; Foreman KE; Gutierrez-Steil C; Nickoloff BJ
J Dermatol Sci; 1997 Nov; 16(1):52-8. PubMed ID: 9438908
[TBL] [Abstract][Full Text] [Related]
38. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
[TBL] [Abstract][Full Text] [Related]
39. Deep dermatofibrosarcoma protuberans: a subcutaneous variant.
Diaz-Cascajo C; Weyers W; Rey-Lopez A; Borghi S
Histopathology; 1998 Jun; 32(6):552-5. PubMed ID: 9675595
[TBL] [Abstract][Full Text] [Related]
40. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis.
Sabater-Marco V; Pérez-Vallés A; Berzal-Cantalejo F; Rodriguez-Serna M; Martinez-Diaz F; Martorell-Cebollada M
Int J Dermatol; 2006 Jan; 45(1):59-62. PubMed ID: 16426380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
